FDA Expands Approval of Treatment for GPP FDA Expands Approval of Treatment for GPP

Spesolimab-sbzo was initially approved in 2022 for treating flares of generalized pustular psoriasis in adults.Medscape Medical News

Source: Medscape Medical News Headlines - March 20, 2024 Category: Consumer Health News Tags: Dermatology Source Type: news